GEERT CAUWENBERGH Insider Trading $PHIO Phio Pharmaceuticals Corp.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for GEERT CAUWENBERGH.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of GEERT CAUWENBERGH. GEERT CAUWENBERGH is Chief Executive Officer in BARRIER THERAPEUTICS INC ($BTRX) and Chief Executive Officer in Phio Pharmaceuticals Corp. ($RXII) and Director in Phio Pharmaceuticals Corp. ($PHIO) and President & CEO in RXi Pharmaceuticals Corp ($RXII).

GEERT CAUWENBERGH in Phio Pharmaceuticals Corp.

Trading Symbol: PHIO
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of GEERT CAUWENBERGH: Director, Chief Executive Officer, President & CEO
Holdings: 22,822 shares
Current Value: $14,606
Latest Transaction: Mar 03 2021
$PHIO Market Capitalization: $4.88M
$PHIO Previous Close: $0.64

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of GEERT CAUWENBERGH in Phio Pharmaceuticals Corp.

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, BTRX, PHIO

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Mar 03 2021PHIOPhio Pharmaceutica ...CAUWENBERGH GEERTDirectorGrantA0.0010,000022,82212.8 K to 22.8 K (+77.99 %)
Nov 20 2019PHIOPhio Pharmaceutica ...CAUWENBERGH GEERTDirectorGrantA0.10225,00022,500704,841479.8 K to 704.8 K (+46.89 %)
Aug 02 2019PHIOPhio Pharmaceutica ...CAUWENBERGH GEERTDirectorPayment of ExerciseF0.401,751706479,841481.6 K to 479.8 K (-0.36 %)
Mar 01 2019RXIIPhio Pharmaceutica ...CAUWENBERGH GEERTChief Executive Off ...GrantA0.38152,41557,887481,592329.2 K to 481.6 K (+46.30 %)
Feb 19 2019RXIIPhio Pharmaceutica ...CAUWENBERGH GEERTChief Executive Off ...GrantA0.3622,2798,096329,177306.9 K to 329.2 K (+7.26 %)
Feb 04 2019RXIIPhio Pharmaceutica ...CAUWENBERGH GEERTChief Executive Off ...GrantA0.3821,4708,096306,898285.4 K to 306.9 K (+7.52 %)
Jan 22 2019RXIIPhio Pharmaceutica ...CAUWENBERGH GEERTChief Executive Off ...GrantA0.3423,7298,096285,428261.7 K to 285.4 K (+9.07 %)
Jan 07 2019RXIIPhio Pharmaceutica ...CAUWENBERGH GEERTChief Executive Off ...GrantA0.3523,1398,096261,699238.6 K to 261.7 K (+9.70 %)
Dec 26 2018RXIIPhio Pharmaceutica ...CAUWENBERGH GEERTChief Executive Off ...GrantA0.3027,4458,096238,560211.1 K to 238.6 K (+13.00 %)
Dec 10 2018RXIIPhio Pharmaceutica ...CAUWENBERGH GEERTChief Executive Off ...GrantA0.3721,8828,096211,115189.2 K to 211.1 K (+11.56 %)
Nov 26 2018RXIIPhio Pharmaceutica ...CAUWENBERGH GEERTChief Executive Off ...GrantA0.3125,9418,096189,233163.3 K to 189.2 K (+15.89 %)
Nov 13 2018RXIIRXi Pharmaceutical ...CAUWENBERGH GEERTPresident & CEOGrantA0.4318,6988,096163,292144.6 K to 163.3 K (+12.93 %)
Oct 29 2018RXIIRXi Pharmaceutical ...CAUWENBERGH GEERTPresident & CEOGrantA0.4418,5198,097144,594126.1 K to 144.6 K (+14.69 %)
Oct 15 2018RXIIRXi Pharmaceutical ...CAUWENBERGH GEERTPresident & CEOGrantA0.4717,2308,096126,075108.8 K to 126.1 K (+15.83 %)
Oct 01 2018RXIIRXi Pharmaceutical ...CAUWENBERGH GEERTPresident & CEOGrantA1.1773,58786,097108,84535.3 K to 108.8 K (+208.71 %)
Aug 03 2018RXIIRXi Pharmaceutical ...CAUWENBERGH GEERTPresident & CEOOption ExerciseA1.7921,00037,59021,000
Aug 03 2018RXIIRXi Pharmaceutical ...CAUWENBERGH GEERTPresident & CEOGrantA0.0021,000035,25814.3 K to 35.3 K (+147.29 %)
Oct 02 2017RXIIRXi Pharmaceutical ...CAUWENBERGH GEERTPresident & CEOBuyP0.457,1003,195142,583135.5 K to 142.6 K (+5.24 %)
Oct 02 2017RXIIRXi Pharmaceutical ...CAUWENBERGH GEERTPresident & CEOBuyP0.4620092135,483135.3 K to 135.5 K (+0.15 %)
Oct 02 2017RXIIRXi Pharmaceutical ...CAUWENBERGH GEERTPresident & CEOBuyP0.442,7001,188135,283132.6 K to 135.3 K (+2.04 %)
Aug 24 2017RXIIRXi Pharmaceutical ...CAUWENBERGH GEERTPresident & CEOBuyP0.56739414132,583131.8 K to 132.6 K (+0.56 %)
Aug 24 2017RXIIRXi Pharmaceutical ...CAUWENBERGH GEERTPresident & CEOBuyP0.554,3612,399131,844127.5 K to 131.8 K (+3.42 %)
Aug 24 2017RXIIRXi Pharmaceutical ...CAUWENBERGH GEERTPresident & CEOBuyP0.554,9002,671127,483122.6 K to 127.5 K (+4.00 %)
Jun 22 2017RXIIRXi Pharmaceutical ...CAUWENBERGH GEERTPresident & CEOBuyP0.625,0003,100122,583117.6 K to 122.6 K (+4.25 %)
Jun 22 2017RXIIRXi Pharmaceutical ...CAUWENBERGH GEERTPresident & CEOBuyP0.635,0003,150117,583112.6 K to 117.6 K (+4.44 %)
Apr 26 2017RXIIRXi Pharmaceutical ...CAUWENBERGH GEERTPresident & CEOBuyP0.6510,0006,480112,583102.6 K to 112.6 K (+9.75 %)
Mar 20 2017RXIIRXi Pharmaceutical ...CAUWENBERGH GEERTPresident & CEOBuyP0.771511102,583102.6 K to 102.6 K (+0.01 %)
Mar 20 2017RXIIRXi Pharmaceutical ...CAUWENBERGH GEERTPresident & CEOBuyP0.77665509102,568101.9 K to 102.6 K (+0.65 %)
Mar 20 2017RXIIRXi Pharmaceutical ...CAUWENBERGH GEERTPresident & CEOBuyP0.779,3207,172101,90392.6 K to 101.9 K (+10.07 %)
Feb 21 2017RXIIRXi Pharmaceutical ...CAUWENBERGH GEERTPresident & CEOBuyP0.702,9172,02792,58389.7 K to 92.6 K (+3.25 %)
Feb 21 2017RXIIRXi Pharmaceutical ...CAUWENBERGH GEERTPresident & CEOBuyP0.696,8834,76689,66682.8 K to 89.7 K (+8.31 %)
Feb 21 2017RXIIRXi Pharmaceutical ...CAUWENBERGH GEERTPresident & CEOBuyP0.6920013882,78382.6 K to 82.8 K (+0.24 %)
Feb 08 2017RXIIRXi Pharmaceutical ...CAUWENBERGH GEERTPresident & CEOBuyP0.6910,0006,85082,58372.6 K to 82.6 K (+13.78 %)
Feb 03 2017RXIIRXi Pharmaceutical ...CAUWENBERGH GEERTPresident & CEOOption ExerciseA0.6313,0008,17713,000
Jan 26 2017RXIIRXi Pharmaceutical ...CAUWENBERGH GEERTPresident & CEOBuyP0.709,7006,75972,58362.9 K to 72.6 K (+15.43 %)
Jan 26 2017RXIIRXi Pharmaceutical ...CAUWENBERGH GEERTPresident & CEOBuyP0.6930020762,88362.6 K to 62.9 K (+0.48 %)
Jan 19 2017RXIIRXi Pharmaceutical ...CAUWENBERGH GEERTPresident & CEOBuyP0.6960041762,58362 K to 62.6 K (+0.97 %)
Jan 19 2017RXIIRXi Pharmaceutical ...CAUWENBERGH GEERTPresident & CEOBuyP0.693,0002,08461,98359 K to 62 K (+5.09 %)
Jan 19 2017RXIIRXi Pharmaceutical ...CAUWENBERGH GEERTPresident & CEOBuyP0.706,4004,44858,98352.6 K to 59 K (+12.17 %)
Jan 03 2017RXIIRXi Pharmaceutical ...CAUWENBERGH GEERTPresident & CEOGrantA0.732,0001,45252,58350.6 K to 52.6 K (+3.95 %)
Dec 27 2016RXIIRXi Pharmaceutical ...CAUWENBERGH GEERTPresident & CEOGrantA0.723,0002,1574,5001.5 K to 4.5 K (+200.00 %)
Dec 23 2016RXIIRXi Pharmaceutical ...CAUWENBERGH GEERTPresident & CEOGrantA0.753,0002,24753,58350.6 K to 53.6 K (+5.93 %)
Dec 20 2016RXIIRXi Pharmaceutical ...CAUWENBERGH GEERTPresident & CEOOption ExerciseA0.9033,33330,00033,333
Dec 20 2016RXIIRXi Pharmaceutical ...CAUWENBERGH GEERTPresident & CEOGrantA0.9033,33330,00050,58317.3 K to 50.6 K (+193.23 %)
Feb 12 2016RXIIRXi Pharmaceutical ...CAUWENBERGH GEERTPresident & CEOOption ExerciseA0.29133,00038,011133,000
Jun 23 2015RXIIRXi Pharmaceutical ...CAUWENBERGH GEERTPresident & CEOOption ExerciseX0.4635,00015,9250
Jun 23 2015RXIIRXi Pharmaceutical ...CAUWENBERGH GEERTPresident & CEOBuyX0.4635,00015,925172,500137.5 K to 172.5 K (+25.45 %)
Jun 03 2015RXIIRXi Pharmaceutical ...CAUWENBERGH GEERTPresident & CEOOption ExerciseA0.525,0002,6005,000
Jun 03 2015RXIIRXi Pharmaceutical ...CAUWENBERGH GEERTPresident & CEOOption ExerciseA0.465,0002,2755,000
Jun 03 2015RXIIRXi Pharmaceutical ...CAUWENBERGH GEERTPresident & CEOOption ExerciseA0.5235,00018,20035,000
Jun 03 2015RXIIRXi Pharmaceutical ...CAUWENBERGH GEERTPresident & CEOOption ExerciseA0.4635,00015,92535,000
Jun 03 2015RXIIRXi Pharmaceutical ...CAUWENBERGH GEERTPresident & CEOGrantA0.4010,0004,00015,0005 K to 15 K (+200.00 %)
Jun 03 2015RXIIRXi Pharmaceutical ...CAUWENBERGH GEERTPresident & CEOGrantA0.4070,00028,000137,50067.5 K to 137.5 K (+103.70 %)
Jun 02 2015RXIIRXi Pharmaceutical ...CAUWENBERGH GEERTPresident & CEOOption ExerciseA0.38133,00050,540133,000
Apr 02 2015RXIIRXi Pharmaceutical ...CAUWENBERGH GEERTPresident & CEOBuyP0.725,0003,59667,50062.5 K to 67.5 K (+8.00 %)

Page:   1

Contact us | Follow us on Twitter